Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: A systematic review.

American college of rheumatology Cognitive impairment Lupus Neuropsychological assessment Systemic lupus erythematosus

Journal

Seminars in arthritis and rheumatism
ISSN: 1532-866X
Titre abrégé: Semin Arthritis Rheum
Pays: United States
ID NLM: 1306053

Informations de publication

Date de publication:
08 2021
Historique:
received: 19 01 2021
revised: 03 05 2021
accepted: 31 05 2021
pubmed: 23 6 2021
medline: 25 2 2023
entrez: 22 6 2021
Statut: ppublish

Résumé

To review: 1) degree of conformity to the American College of Rheumatology neuropsychological battery (ACR-NB) among studies that used a NB, 2) review definitions of cognitive impairment (CI) from studies that used a NB, and 3) characterize measurement tools used to assess CI in systemic lupus erythematosus (SLE). The literature search was conducted in Ovid Medline, Embase, and PsycINFO for articles on CI in adult SLE patients. We reviewed studies that used a NB and compared their tests to the ACR-NB to assess the degree of conformity. Definitions of CI from studies that used a NB were reviewed when sufficient information was available. We reviewed and categorized CI measurement tools into four broad categories: NB, screening, incomplete/mixed batteries, and computerized batteries. Of 8727 references, 118 were selected for detailed review and 97 were included in the final analysis. Of 43 studies that used a NB, none of the studies used the ACR-NB exactly as published. Many studies supplemented with other tests. Overall, there was inconsistent use of ACR-NB tests. Definitions for CI varied, with cut-offs ranging from 1 to 3 standard deviations below normative values on domains/tests varying in type and number. The most frequently used measurement tool for assessing CI in SLE was a NB. Use of screening tests and computerized batteries have also increased over the last decade. The assessment and definition of CI in SLE remains heterogeneous. A consensus meeting to address existing inconsistencies should be considered to harmonize the field of CI in SLE.

Identifiants

pubmed: 34157577
pii: S0049-0172(21)00110-4
doi: 10.1016/j.semarthrit.2021.05.018
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

819-830

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Kimberley Yuen (K)

Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto Lupus Clinic, EW, 1-412, 399 Bathurst Street, Toronto, Ontario, Canada; Queen's University School of Medicine, Kingston, Ontario, Canada.

Robin Green (R)

University Health Network- Toronto Rehabilitation Institute, Toronto, Ontario, Canada.

Kathleen Bingham (K)

University Health Network Centre for Mental Health, Toronto, Ontario, Canada.

Lesley Ruttan (L)

University Health Network- Toronto Rehabilitation Institute, Toronto, Ontario, Canada.

Victoria Lee-Kim (V)

Queen's University School of Medicine, Kingston, Ontario, Canada.

Maria Carmela Tartaglia (MC)

Krembil Neurosciences Centre, University of Toronto, Toronto, Ontario, Canada.

Melanie Anderson (M)

Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Moe Zandy (M)

Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto Lupus Clinic, EW, 1-412, 399 Bathurst Street, Toronto, Ontario, Canada.

May Y Choi (MY)

Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Marvin J Fritzler (MJ)

Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Joan E Wither (JE)

Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.

Dorcas E Beaton (DE)

Institute for Work and Health, Toronto, Ontario, Canada.

Patricia Katz (P)

University of California at San Francisco, San Francisco, California, USA.

Zahi Touma (Z)

Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto Lupus Clinic, EW, 1-412, 399 Bathurst Street, Toronto, Ontario, Canada. Electronic address: zahi.touma@uhn.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH